Printer Friendly

CTFA files comments on topical antimicrobials.

* The CTFA and The Soap and Detergent Association (SDA) submitted three separate comments to the Food and Drug Administration (FDA) as it develops a final monograph for Over-the-Counter (OTC) Health-Care Antiseptic Drug Products. The data and information were submitted in response to FDA's limited reopening of the docket for topical antimicrobial drug products.

In 1997, an independent review panel for the FDA reported that resistance was not an issue under current conditions of topical antimicrobial product usage. The Coalition noted that the latest research shared with the agency validates that conclusion.

The Coalition also provided additional data on the benefits of health care professional products published since the Coalition's previous submission to the FDA in 2001. Additionally, CTFA/SDA stated that FDA should be open to receiving new data on the benefits of antimicrobial products beyond the recent deadline for submitting additional comments and data.

In other news, the CTFA filed two citizen petitions with the FDA regarding updated information and data on SPF and anti-aging claims for sunscreens. The FDA is reviewing the Sunscreen Monograph adopted in May of 1999, and plans to publish proposed amendments in December. One petition supports SPF claims higher than 30 and the second petition supports anti-aging claims on sunscreens. Both were banned in 1999. More info: www.ctfa.org.
COPYRIGHT 2003 Rodman Publications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Regulations
Publication:Household & Personal Products Industry
Date:Nov 1, 2003
Words:216
Previous Article:NJ proposes new consumer product VOC rule.
Next Article:Pola USA's signs solutions uses cell renewal theory.


Related Articles
Regulations.
CTFA AND SDA TEAM UP FOR OTC LABEL PETITION.
CTFA ADDRESSES ISSUES AT LEGISLATIVE DAY.
California may consider proposition 65 reforms. (Regulations).
SDA and CTFA petition FDA on anti-viral labeling. (Regulations).
CTFA opposes California tax on manufacturers. (Regulations).
SDA, CTFA provide FDA with antimicrobial data. (Regulations).
Antimicrobial products not linked to antibiotic resistance.
CTFA stresses consumer benefit of microparticles.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters